Skip to main content
. 2019 Dec 9;21:272. doi: 10.1186/s13075-019-2037-1

Table 2.

Baseline PRO scores

PRO measures Baseline, mean ± SD
PBO, n = 221 UPA 15 mg, n = 221 UPA 30 mg, n = 219
PtGA (mm) 60.3 ± 20.5 63.1 ± 21.9 62.8 ± 20.3
Pain VAS (mm) 61.5 ± 20.8 64.1 ± 19.5 64.0 ± 19.8
HAQ-DI 1.4 ± 0.6 1.5 ± 0.6 1.5 ± 0.6
FACIT-F 28.3 ± 11.5 28.1 ± 11.1 27.5 ± 12.6
SF-36 component scores
 PCS 33.1 ± 7.7 33.4 ± 7.4 32.6 ± 7.9
 MCS 46.5 ± 11.7 45.9 ± 10.9 46.1 ± 12.0
SF-36 domainsa
 PF 33.3 ± 9.4 33.5 ± 8.8 32.9 ± 9.7
 RP 35.4 ± 8.1 35.5 ± 8.5 34.7 ± 8.9
 BP 35.3 ± 6.9 35.5 ± 6.4 34.6 ± 6.8
 GH 39.2 ± 9.0 38.9 ± 8.1 39.1 ± 9.4
 VT 41.8 ± 9.0 41.5 ± 9.0 41.2 ± 10.0
 SF 40.8 ± 10.8 40.6 ± 9.9 40.8 ± 11.0
 RE 42.2 ± 11.9 41.1 ± 11.7 41.1 ± 11.9
 MH 43.8 ± 10.7 44.1 ± 9.9 44.0 ± 11.5
SF-6D Utility Index 0.57 ± 0.1 0.57 ± 0.1 0.57 ± 0.1
EQ-5D-5 L Index 0.6 ± 0.2 0.6 ± 0.3 0.6 ± 0.3
EQ-5D VAS (mm) 51.4 ± 21.5 49.6 ± 21.3 49.0 ± 22.0
AM joint stiffness
 Duration (min) 138.9 ± 214.0 152.4 ± 241.9 128.6 ± 156.0
 Severityb 6.1 ± 2.2 6.1 ± 2.4 6.2 ± 2.2
 RA-WISc 12.2 ± 6.1 12.9 ± 5.5 13.5 ± 6.5

AM morning, BP Bodily Pain, CI confidence interval, FACIT-F Functional Assessment of Chronic Illness Therapy-Fatigue, GH General Health, HAQ-DI Health Assessment Questionnaire-Disability Index, LSM least squares mean, MCS mental component summary, MH Mental Health, PBO placebo, PCS physical component summary, PF Physical Functioning, PRO patient-reported outcome, PtGA Patient’s Global Assessment of Disease Activity, RA-WIS Work Instability Scale for RA, RE Role-Emotional, RP Role-Physical, SD standard deviation, SF Social Functioning, SF-36 Short Form 36 Health Survey, UPA upadacitinib, VAS visual analogue scale, VT Vitality

aThe baseline values and LSM changes for SF-36 domains were transformed based on the mean and standard deviation of the 1998 general US population

bAssessed on a numeric scale of 1 to 10, with 10 being the worst level

cCalculated only for employed patients